OraSure Technologies Inc.
05/09/2025 | Press release | Distributed by Public on 05/09/2025 05:20
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On May 8, 2025, Kathleen G. Weber notified OraSure Technologies, Inc. (the "Company") of her resignation as Chief Product Officer of the Company, effective June 30, 2025. Ms. Weber's resignation will be treated as a resignation for "Good Reason," as such term is defined in Amendment No. 2 to that certain Employment Agreement, dated as of January 1, 2019 (as amended, the "Employment Agreement"), by and among Ms. Weber, the Company, and DNA Genotek Inc., the Company's wholly-owned subsidiary. Ms. Weber will be entitled to the severance benefits set forth in the Employment Agreement consistent with a resignation for "Good Reason." All severance benefits are contingent upon Ms. Weber's execution of a general release of claims against the Company. The Employment Agreement and each amendment thereto are filed as Exhibits 10.1, 10.2 and 10.3 to the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the Securities and Exchange Commission on March 7, 2025.
OraSure Technologies Inc. published this content on May 09, 2025, and is solely responsible for the information contained herein. Distributed via SEC EDGAR on May 09, 2025 at 11:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at support@pubt.io